HSF1 and endometrial carcinoma: High levels of HSF1 expression in tumor tissues has been reported to be associated with poor progression in patients with breast cancer [16], endometrial carcinoma [11], hepatocellular carcinoma [17] and Hodgkin’s lymphoma [18].